[Congressional Record Volume 142, Number 137 (Saturday, September 28, 1996)]
[Senate]
[Pages S11764-S11770]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




        NATIONAL INSTITUTES OF HEALTH REVITALIZATION ACT OF 1996

  The text of the bill (S. 1897) to amend the Public Health Service Act 
to revise and extend certain programs relating to the National 
Institutes of Health, and for other purposes; as passed by the Senate 
on September 26, 1996, is as follows:
       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. SHORT TITLE; REFERENCES; AND TABLE OF CONTENTS

       (a) Short Title.--This Act may be cited as the ``National 
     Institutes of Health Revitalization Act of 1996''.
       (b) References.--Whenever in this Act an amendment is 
     expressed in terms of an amendment to a section or other 
     provision, the reference shall be considered to be made to a 
     section or other provision of the Public Health Service Act 
     (42 U.S.C. 201 et seq.).
       (c) Table of Contents.--The table of contents for this Act 
     is as follows:

Sec. 1. Short title; references; and table of contents

   TITLE I--PROVISIONS RELATING TO THE NATIONAL INSTITUTES OF HEALTH

Sec. 101. Director's discretionary fund.
Sec. 102. Children's vaccine initiative.

[[Page S11765]]

   TITLE II--PROVISIONS RELATING TO THE NATIONAL RESEARCH INSTITUTES

Sec. 201. Research on osteoporosis, paget's disease, and related bone 
              disorders.
Sec. 202. National Human Genome Research Institute.
Sec. 203. Increased amount of grant and other awards.
Sec. 204. Meetings of advisory committees and councils.
Sec. 205. Elimination or modification of reports.

               TITLE III--SPECIFIC INSTITUTES AND CENTERS

                 Subtitle A--National Cancer Institute

Sec. 301. Authorization of appropriations.
Sec. 302. DES study.

          Subtitle B--National Heart Lung and Blood Institute

Sec. 311. Authorization of appropriations.

   Subtitle C--National Institute of Allergy and Infectious Diseases

Sec. 321. Terry Beirn community-based AIDS research initiative.

  Subtitle D--National Institute of Child Health and Human Development

Sec. 331. Research centers for contraception and infertility.

                Subtitle E--National Institute on Aging

Sec. 341. Authorization of appropriations.

     Subtitle F--National Institute on Alcohol Abuse and Alcoholism

Sec. 351. Authorization of appropriations.
Sec. 352. National Alcohol Research Center.

              Subtitle G--National Institute on Drug Abuse

Sec. 361. Authorization of appropriations.
Sec. 362. Medication development program.
Sec. 363. Drug Abuse Research Centers.

            Subtitle H--National Institute of Mental Health

Sec. 371. Authorization of appropriations.

           Subtitle I--National Center for Research Resources

Sec. 381. Authorization of appropriations.
Sec. 382. General Clinical Research Centers.
Sec. 383. Enhancement awards.
Sec. 384. Waiver of limitations.

                Subtitle J--National Library of Medicine

Sec. 391. Authorization of appropriations.
Sec. 392. Increasing the cap on grant amounts.

                     TITLE IV--AWARDS AND TRAINING

Sec. 401. Medical scientist training program.
Sec. 402. Raise in maximum level of loan repayments.
Sec. 403. General loan repayment program.
Sec. 404. Clinical research assistance.

                 TITLE V--RESEARCH WITH RESPECT TO AIDS

Sec. 501. Comprehensive plan for expenditure of AIDS appropriations.
Sec. 502. Emergency AIDS discretionary fund.

                      TITLE VI--GENERAL PROVISIONS

              Subtitle A--Authority of the Director of NIH

Sec. 601. Authority of the Director of NIH.

              Subtitle B--Office of Rare Disease Research

Sec. 611. Establishment of Office for Rare Disease Research.

                  Subtitle C--Certain Reauthorizations

Sec. 621. National Research Service Awards.
Sec. 622. National Foundation for Biomedical Research.

                  Subtitle D--Miscellaneous Provisions

Sec. 631. Establishment of National Fund for Health Research.
Sec. 632. Definition of clinical research.
Sec. 633. Establishment of a pediatric research initiative.
Sec. 634. Diabetes research.
Sec. 635. Parkinson's research.
Sec. 636. Pain research consortium.

             Subtitle E--Repeals and Conforming Amendments

Sec. 641. Repeals and conforming amendments.
   TITLE I--PROVISIONS RELATING TO THE NATIONAL INSTITUTES OF HEALTH

     SEC. 101. DIRECTOR'S DISCRETIONARY FUND.

       Section 402(i)(3) (42 U.S.C. 282(i)(3)) is amended by 
     striking ``$25,000,000'' and all that follows through the 
     period and inserting ``such sums as may be necessary for 
     fiscal year 1997.''.

     SEC. 102. CHILDREN'S VACCINE INITIATIVE.

       Section 404B(c) (42 U.S.C. 283d(c)) is amended by striking 
     ``$20,000,000'' and all that follows through the period and 
     inserting ``such sums as may be necessary for fiscal year 
     1997.''.
   TITLE II--PROVISIONS RELATING TO THE NATIONAL RESEARCH INSTITUTES

     SEC. 201. RESEARCH ON OSTEOPOROSIS, PAGET'S DISEASE, AND 
                   RELATED BONE DISORDERS.

       Section 409A(d) (42 U.S.C. 284e(d)) is amended by striking 
     ``$40,000,000'' and all that follows through the period and 
     inserting ``such sums as may be necessary for fiscal year 
     1997.''.

     SEC. 202. NATIONAL HUMAN GENOME RESEARCH INSTITUTE.

       (a) In General.--Part C of title IV (42 U.S.C. 285 et seq.) 
     is amended by adding at the end thereof the following new 
     subpart:

         ``Subpart 18--National Human Genome Research Institute

     ``SEC. 464Z. PURPOSE OF THE INSTITUTE.

       ``(a) In General.--The general purpose of the National 
     Human Genome Research Institute is to characterize the 
     structure and function of the human genome, including the 
     mapping and sequencing of individual genes. Such purpose 
     includes--
       ``(1) planning and coordinating the research goal of the 
     genome project;
       ``(2) reviewing and funding research proposals;
       ``(3) conducting and supporting research training;
       ``(4) coordinating international genome research;
       ``(5) communicating advances in genome science to the 
     public;
       ``(6) reviewing and funding proposals to address the 
     ethical, legal, and social issues associated with the genome 
     project (including legal issues regarding patents); and
       ``(7) planning and administering intramural, collaborative, 
     and field research to study human genetic disease.
       ``(b) Research.--The Director of the Institute may conduct 
     and support research training--
       ``(1) for which fellowship support is not provided under 
     section 487; and
       ``(2) that is not residency training of physicians or other 
     health professionals.
       ``(c) Ethical, Legal, and Social Issues.--
       ``(1) In general.--Except as provided in paragraph (2), of 
     the amounts appropriated to carry out subsection (a) for a 
     fiscal year, the Director of the Institute shall make 
     available not less than 5 percent of amounts made available 
     for extramural research for carrying out paragraph (6) of 
     such subsection.
       ``(2) Nonapplication.--With respect to providing funds 
     under subsection (a)(6) for proposals to address the ethical 
     issues associated with the genome project, paragraph (1) 
     shall not apply for a fiscal year if the Director of the 
     Institute certifies to the Committee on Commerce of the House 
     of Representatives, and to the Committee on Labor and Human 
     Resources of the Senate, that the Director has determined 
     that an insufficient number of such proposals meet the 
     applicable requirements of sections 491 and 492.
       ``(d) Transfer.--
       ``(1) In general.--There are transferred to the National 
     Human Genome Research Institute all functions which the 
     National Center for Human Genome Research exercised before 
     the date of enactment of this subpart, including all related 
     functions of any officer or employee of the National Center 
     for Human Genome Research. The personnel employed in 
     connection with, and the assets, liabilities, contracts, 
     property, records, and unexpended balances of appropriations, 
     authorizations, allocations, and other funds employed, used, 
     held, arising from, available to, or to be made available in 
     connection with the functions transferred under this 
     subsection shall be transferred to the National Human Genome 
     Research Institute.
       ``(2) Legal documents.--All orders, determinations, rules, 
     regulations, permits, agreements, grants, contracts, 
     certificates, licenses, regulations, privileges, and other 
     administrative actions which have been issued, made, granted, 
     or allowed to become effective in the performance of 
     functions which are transferred under this subsection shall 
     continue in effect according to their terms until modified, 
     terminated, superseded, set aside, or revoked in accordance 
     with law.
       ``(3) References.--References in any other Federal law, 
     Executive order, rule, regulation, or delegation of 
     authority, or any document of or relating to the National 
     Center for Human Genome Research shall be deemed to refer to 
     the National Human Genome Research Institute.
       ``(e) Authorization of Appropriations.--There are 
     authorized to be appropriated to carry out this section, such 
     sums as may be necessary for fiscal year 1997.''.
       (b) Conforming Amendments.--
       (1) Section 401(b) (42 U.S.C. 281(b)) is amended--
       (A) in paragraph (1), by adding at the end thereof the 
     following new subparagraph:
       ``(R) The National Human Genome Research Institute.''; and
       (B) in paragraph (2)--
       (i) by striking subparagraph (D); and
       (ii) by redesignating subparagraph (E) as subparagraph (D).
       (2) Subpart 3 of part E of title IV (42 U.S.C. 287c et 
     seq.) is repealed.

     SEC. 203. INCREASED AMOUNT OF GRANT AND OTHER AWARDS.

       Section 405(b)(2)(B) (42 U.S.C. 284(b)(2)(B) is amended--
       (1) in clause (i), by striking ``$50,000'' and inserting 
     ``$100,000''; and
       (2) in clause (ii), by striking ``$50,000'' and inserting 
     ``$100,000''.

     SEC. 204. MEETINGS OF ADVISORY COMMITTEES AND COUNCILS.

       (a) In General.--Section 406 (42 U.S.C. 284a) is amended--
       (1) in subsection (e), by striking ``, but at least three 
     times each fiscal year''; and
       (2) in subsection (h)(2)--
       (A) in subparagraph (A)--
       (i) in clause (iv), by adding ``and'' after the semicolon;
       (ii) in clause (v), by striking ``; and'' and inserting a 
     period; and
       (iii) by striking clause (vi); and
       (B) in subparagraph (B), by striking ``, except'' and all 
     that follows through ``year''.
       (b) President's Cancer Panel.--Section 415(a)(3) (42 U.S.C. 
     285a-4(a)(3)) is amended by striking ``, but not less often 
     than four times a year''.

[[Page S11766]]

       (c) Institute of Diabetes and Digestive and Kidney Diseases 
     Interagency Coordinating Committees.--Section 429(b) (42 
     U.S.C. 285c-3(b)) is amended by striking ``, but not less 
     often than four times a year''.
       (d) Institute of Arthritis and Musculoskeletal and Skin 
     Diseases Interagency Coordinating Committees.--Section 439(b) 
     (42 U.S.C. 285d-4(b)) is amended by striking ``, but not less 
     often than four times a year''.
       (e) Institute on Deafness and Other Communication Disorders 
     Interagency Coordinating Committees.--Section 464E(d) (42 
     U.S.C. 285m-5(d)) is amended by striking ``, but not less 
     often than four times a year''.
       (f) Institute of Nursing Research Advisory Council.--
     Section 464X(e) (42 U.S.C. 285q-2(e)) is amended by striking 
     ``, but at least three times each fiscal year''.
       (g) Center for Research Resources Advisory Council.--
     Section 480(e) (42 U.S.C. 287a(e)) is amended by striking ``, 
     but at least three times each fiscal year''.
       (h) Application of FACA.--Part B of title IV (42 U.S.C. 284 
     et seq.) is amended by adding at the end thereof the 
     following new section:

     ``SEC. 409B. APPLICATION OF FEDERAL ADVISORY COMMITTEE ACT.

       ``Notwithstanding any other provision of law, the 
     provisions of the Federal Advisory Committee Act (5 U.S.C. 
     App. 2) shall not apply to a scientific or technical peer 
     review group, established under this title.''.

     SEC. 205. ELIMINATION OR MODIFICATION OF REPORTS.

       (a) Public Health Service Act Reports.--The following 
     provisions of the Public Health Service Act are repealed:
       (1) Section 403 (42 U.S.C. 283) relating to the biennial 
     report of the Director of the National Institutes of Health 
     to Congress and the President.
       (2) Subsection (c) of section 439 (42 U.S.C. 285d-4(c)) 
     relating to the annual report of the Arthritis and 
     Musculoskeletal Diseases Interagency Coordinating Committee 
     and the annual report of the Skin Diseases Interagency 
     Coordinating Committee.
       (3) Subsection (j) of section 442 (42 U.S.C. 285d-7(j)) 
     relating to the annual report of the National Arthritis and 
     Musculoskeletal and Skin Diseases Advisory Board.
       (4) Subsection (b) of section 494A (42 U.S.C. 289c-1(b)) 
     relating to the annual report of the Secretary of Health and 
     Human Services on health services research relating to 
     alcohol abuse and alcoholism, drug abuse, and mental health.
       (5) Subsection (b) of section 503 (42 U.S.C. 290aa-2(b)) 
     relating to the triennial report of the Secretary of Health 
     and Human Services to Congress.
       (b) Report on Disease Prevention.--Section 402(f)(3) (42 
     U.S.C. 282(f)(3)) is amended by striking ``annually'' and 
     inserting ``biennially''.
       (c) Reports of the Coordinating Committees on Digestive 
     Diseases, Diabetes Mellitus, and Kidney, Urologic and 
     Hematologic Diseases.--Section 429 (42 U.S.C. 285c-3) is 
     amended by striking subsection (c).
       (d) Report of the Task Force on Aging Research.--Section 
     304 of the Home Health Care and Alzheimer's Disease 
     Amendments of 1990 (42 U.S.C. 242q-3) is repealed.
       (e) Sudden Infant Death Syndrome Research.--Section 1122 
     (42 U.S.C. 300c-12) is amended--
       (1) in subsection (a)--
       (A) by striking the subsection designation and heading; and
       (B) by striking ``of the type'' and all that follows 
     through ``adequate,'' and insert ``, such amounts each year 
     as will be adequate for research which relates generally to 
     sudden infant death syndrome, including high-risk pregnancy 
     and high-risk infancy research which directly relates to 
     sudden infant death syndrome, and to the relationship of the 
     high-risk pregnancy and high-risk infancy research to sudden 
     infant death syndrome,''; and
       (2) by striking subsections (b) and (c).
       (f) U.S.-Japan Cooperative Medical Science Program.--
     Subsection (h) of section 5 of the International Health 
     Research Act of 1960 is repealed.
       (g) Bioengineering Research.--Not later than 6 months after 
     the date of enactment of this Act, the Secretary of Health 
     and Human Services, acting through the Director of the 
     National Institutes of Health, shall prepare and submit to 
     the Committee on Labor and Human Resources of the Senate and 
     the Committee on Commerce of the House of Representatives, a 
     report containing specific plans and timeframes on how the 
     Director will implement the findings and recommendations of 
     the report to Congress entitled ``Support for Bioengineering 
     Research'' (submitted in August of 1995 in accordance with 
     section 1912 of the National Institutes of Health 
     Revitalization Act of 1993 (42 U.S.C. 282 note)).
       (h) Conforming Amendments.--Title IV is amended--
       (1) in section 404C(c) (42 U.S.C. 283e(c)), by striking 
     ``included'' and all that follows through the period and 
     inserting ``made available to the committee established under 
     subsection (e) and included in the official minutes of the 
     committee'';
       (2) in section 404E(d)(3)(B) (42 U.S.C. 283g(d)(3)(B)), by 
     striking ``for inclusion in the biennial report under section 
     403'';
       (3) in section 406(g) (42 U.S.C. 284a(g))--
       (A) by striking ``for inclusion in the biennial report made 
     under section 407'' and inserting ``as it may determine 
     appropriate''; and
       (B) by striking the second sentence;
       (4) in section 407 (42 U.S.C. 284b)--
       (A) in the section heading, to read as follows:


                              ``reports'';

     and
       (B) by striking ``shall prepare for inclusion in the 
     biennial report made under section 403 a biennial'' and 
     inserting ``may prepare a'';
       (5) in section 416(b) (42 U.S.C. 285a-5(b)) by striking 
     ``407'' and inserting ``402(f)(3)'';
       (6) in section 417 (42 U.S.C. 285a-6), by striking 
     subsection (e);
       (7) in section 423(b) (42 U.S.C. 285b-6(b)), by striking 
     ``407'' and inserting ``402(f)(3)'';
       (8) by striking section 433 (42 U.S.C. 285c-7);
       (9) in section 451(b) (42 U.S.C. 285g-3(b)), by striking 
     ``407'' and inserting ``402(f)(3)'';
       (10) in section 452(d) (42 U.S.C. 285g-4(d))--
       (A) in paragraph (3)--
       (i) in subparagraph (A), by striking ``(A) Not'' and 
     inserting ``Not''; and
       (ii) by striking subparagraph (B); and
       (B) in the last sentence of paragraph (4), by striking 
     ``contained'' and all that follows through the period and 
     inserting ``transmitted to the Director of NIH.'';
       (11) in section 464I(b) (42 U.S.C. 285n-1(b)), by striking 
     ``407'' and inserting ``402(f)(3)'';
       (12) in section 464M(b) (42 U.S.C. 285o-1)(b)), by striking 
     ``407'' and inserting ``402(f)(3)'';
       (13) in section 464S(b) (42 U.S.C. 285p-1(b)), by striking 
     ``407'' and inserting ``402(f)(3)'';
       (14) in section 464X(g) (42 U.S.C. 285q-2(g)) is amended--
       (A) by striking ``for inclusion in the biennial report made 
     under section 464Y'' and inserting ``as it may determine 
     appropriate''; and
       (B) by striking the second sentence;
       (15) in section 464Y (42 U.S.C. 285q-3)--
       (A) in the section heading, to read as follows:


                              ``reports'';

     and
       (B) by striking ``shall prepare for inclusion in the 
     biennial report made under section 403 a biennial'' and 
     inserting ``may prepare a'';
       (16) in section 480(g) (42 U.S.C. 287a(g))--
       (A) by striking ``for inclusion in the biennial report made 
     under section 481'' and inserting ``as it may determine 
     appropriate''; and
       (B) by striking the second sentence;
       (17) in section 481 (42 U.S.C. 287a-1)--
       (A) in the section heading, to read as follows:


                              ``reports'';

     and
       (B) by striking ``shall prepare for inclusion in the 
     biennial report made under section 403 a biennial'' and 
     inserting ``may prepare a'';
       (18) in section 486(d)(5)(B) (42 U.S.C. 287d(d)(5)(B)), by 
     striking ``for inclusion in the report required in section 
     403'';
       (19) in section 486B (42 U.S.C. 287d-2) by striking 
     subsection (b) and inserting the following new subsection:
       ``(b) Submission.--The Director of the Office shall submit 
     each report prepared under subsection (a) to the Director of 
     NIH.''; and
       (20) in section 492B(f) (42 U.S.C. 289a-2(f)), by striking 
     ``for inclusion'' and all that follows through the period and 
     inserting ``and the Director of NIH.''.
               TITLE III--SPECIFIC INSTITUTES AND CENTERS
                 Subtitle A--National Cancer Institute

     SEC. 301. AUTHORIZATION OF APPROPRIATIONS.

       Section 417B (42 U.S.C. 286a-8) is amended--
       (1) in subsection (a), by striking ``$2,728,000,000'' and 
     all that follows through the period and inserting 
     ``$3,000,000,000 for fiscal year 1997.'';
       (2) in subsection (b)--
       (A) in paragraph (1)--
       (i) in the first sentence of subparagraph (A), by striking 
     ``$225,000,000'' and all that follows through the first 
     period and inserting ``such sums as may be necessary for 
     fiscal year 1997.''; and
       (ii) in the first sentence of subparagraph (B), by striking 
     ``$100,000,000'' and all that follows through the first 
     period and inserting ``such sums as may be necessary for 
     fiscal year 1997.''; and
       (B) in the first sentence of paragraph (2), by striking 
     ``$75,000,000'' and all that follows through the first period 
     and inserting ``such sums as may be necessary for fiscal year 
     1997.''; and
       (3) in the first sentence of subsection (c), by striking 
     ``$72,000,000'' and all that follows through the first period 
     and inserting ``such sums as may be necessary for fiscal year 
     1997.''.

     SEC. 302. DES STUDY.

       Section 403A(e) (42 U.S.C. 283a(e)) is amended by striking 
     ``1996'' and inserting ``1997''.
          Subtitle B--National Heart Lung and Blood Institute

     SEC. 311. AUTHORIZATION OF APPROPRIATIONS.

       Section 425 (42 U.S.C. 285b-8) is amended by striking 
     ``$1,500,000,000'' and all that follows through the period 
     and inserting ``$1,600,000,000 for fiscal year 1997.''.
   Subtitle C--National Institute of Allergy and Infectious Diseases

     SEC. 321. TERRY BEIRN COMMUNITY-BASED AIDS RESEARCH 
                   INITIATIVE.

       Section 2313(e) (42 U.S.C. 300cc-13(e)) is amended--
       (1) in paragraph (1), by striking ``1996'' and inserting 
     ``1997''; and
       (2) in paragraph (2), by striking ``1996'' and inserting 
     ``1997''.

[[Page S11767]]

  Subtitle D--National Institute of Child Health and Human Development

     SEC. 331. RESEARCH CENTERS FOR CONTRACEPTION AND INFERTILITY.

       Section 452A(g) (42 U.S.C. 285g-5(g)) is amended by 
     striking ``$30,000,000'' and all that follows through the 
     period and inserting ``such sums as may be necessary for 
     fiscal year 1997.''.
                Subtitle E--National Institute on Aging

     SEC. 341. AUTHORIZATION OF APPROPRIATIONS.

       Section 445I (42 U.S.C. 285e-11) is amended by striking 
     ``$500,000,000'' and all that follows through the period and 
     inserting ``$550,000,000 for fiscal year 1997.''.
     Subtitle F--National Institute on Alcohol Abuse and Alcoholism

     SEC. 351. AUTHORIZATION OF APPROPRIATIONS.

       Section 464H(d)(1) (42 U.S.C. 285n(d)(1)) is amended by 
     striking ``300,000,000'' and all that follows through the 
     period and inserting ``$330,000,000 for fiscal year 1997.''.

     SEC. 352. NATIONAL ALCOHOL RESEARCH CENTER.

       Section 464J(b) (42 U.S.C. 285n-2(b)) is amended--
       (1) by striking ``(b) The'' and inserting ``(b)(1) The'';
       (2) by striking the third sentence; and
       (3) by adding at the end thereof the following new 
     paragraph:
       ``(2) As used in paragraph (1), the terms `construction' 
     and `cost of construction' include--
       ``(A) the construction of new buildings, the expansion of 
     existing buildings, and the acquisition, remodeling, 
     replacement, renovation, major repair (to the extent 
     permitted by regulations), or alteration of existing 
     buildings, including architects' fees, but not including the 
     cost of the acquisition of land or offsite improvements; and
       ``(B) the initial equipping of new buildings and of the 
     expanded, remodeled, repaired, renovated, or altered part of 
     existing buildings; except that

     such term shall not include the construction or cost of 
     construction of so much of any facility as is used or is to 
     be used for sectarian instruction or as a place for religious 
     worship.''.
              Subtitle G--National Institute on Drug Abuse

     SEC. 361. AUTHORIZATION OF APPROPRIATIONS.

       Section 464L(d)(1) (42 U.S.C. 285o(d)(1)) is amended by 
     striking ``$440,000,000'' and all that follows through the 
     period and inserting ``$500,000,000 for fiscal year 1997.''.

     SEC. 362. MEDICATION DEVELOPMENT PROGRAM.

       Section 464P(e) (42 U.S.C. 285o-4(e)) is amended by 
     striking ``$85,000,000'' and all that follows through the 
     period and inserting ``such sums as may be necessary for 
     fiscal year 1997''.

     SEC. 363. DRUG ABUSE RESEARCH CENTERS.

       Section 464N(b) (42 U.S.C. 285o-2(b)) is amended--
       (1) by striking ``(b) The'' and inserting ``(b)(1) The'';
       (2) by striking the last sentence; and
       (3) by adding at the end thereof the following new 
     paragraph:
       ``(2) As used in paragraph (1), the terms `construction' 
     and `cost of construction' include--
       ``(A) the construction of new buildings, the expansion of 
     existing buildings, and the acquisition, remodeling, 
     replacement, renovation, major repair (to the extent 
     permitted by regulations), or alteration of existing 
     buildings, including architects' fees, but not including the 
     cost of the acquisition of land or offsite improvements; and
       ``(B) the initial equipping of new buildings and of the 
     expanded, remodeled, repaired, renovated, or altered part of 
     existing buildings; except that

     such term does not include the construction or cost of 
     construction of so much of any facility as is used or is to 
     be used for sectarian instruction or as a place for religious 
     worship.''.
            Subtitle H--National Institute of Mental Health

     SEC. 371. AUTHORIZATION OF APPROPRIATIONS.

       Section 464R(f)(1) (42 U.S.C. 285p(f)(1)) is amended by 
     striking ``$675,000,000'' and all that follows through the 
     period and inserting ``$750,000,000 for fiscal year 1997.''.
           Subtitle I--National Center for Research Resources

     SEC. 381. AUTHORIZATION OF APPROPRIATIONS.

       (a) General Authorization.--Section 481A(h) (42 U.S.C. 
     287a-2(h)) is amended by striking ``$150,000,000'' and all 
     that follows through the period and inserting ``such sums as 
     may be necessary for fiscal year 1997.''.
       (b) Reservation for Construction of Regional Centers.--
     Section 481B(a) (42 U.S.C. 287a-3(a)) is amended--
       (1) by striking ``shall'' and inserting ``may'';
       (2) by striking ``through 1996'' and inserting ``through 
     1997''; and
       (3) by striking ``$5,000,000'' and inserting ``such sums as 
     may be necessary for each such fiscal year''.

     SEC. 382. GENERAL CLINICAL RESEARCH CENTERS.

       Part B of title IV (42 U.S.C. 284 et seq.), as amended by 
     section 205(h), is further amended by adding at the end 
     thereof the following new section:

     ``SEC. 409C. GENERAL CLINICAL RESEARCH CENTERS.

       ``(a) Grants.--The Director of the National Center for 
     Research Resources shall award grants for the establishment 
     of general clinical research centers to provide the 
     infrastructure for clinical research including clinical 
     research training and career enhancement. Such centers shall 
     support clinical studies and career development in all 
     settings of the hospital or academic medical center involved.
       ``(b) Activities.--In carrying out subsection (a), the 
     Director of NIH shall expand the activities of the general 
     clinical research centers through the increased use of 
     telecommunications and telemedicine initiatives.
       ``(c) Authorization of Appropriations.--There are 
     authorized to be appropriated to make grants under subsection 
     (a), such sums as may be necessary for each of the fiscal 
     years 1996 and 1997.''.

     SEC. 383. ENHANCEMENT AWARDS.

       Part B of title IV (42 U.S.C. 284 et seq.), as amended by 
     sections 205(h) and 382, is further amended by adding at the 
     end thereof the following new section:

     ``SEC. 409D. ENHANCEMENT AWARDS.

       ``(a) Clinical Research Career Enhancement Award.--
       ``(1) In general.--The Director of the National Center for 
     Research Resources shall make grants (to be referred to as 
     `clinical research career enhancement awards') to support 
     individual careers in clinical research.
       ``(2) Applications.--An application for a grant under this 
     subsection shall be submitted by an individual scientist at 
     such time as the Director may require.
       ``(3) Limitations.--The amount of a grant under this 
     subsection shall not exceed $130,000 per year per grant. 
     Grants shall be for terms of 5 years. The Director shall 
     award not more than 20 grants in the first fiscal year in 
     which grants are awarded under this subsection. The total 
     number of grants awarded under this subsection for the first 
     and second fiscal years in which grants such are awarded 
     shall not exceed 40 grants.
       ``(4) Authorization of appropriations.--There are 
     authorized to be appropriated to make grants under paragraph 
     (1), such sums as may be necessary for fiscal year 1997.
       ``(b) Innovative Medical Science Award.--
       ``(1) In general.--The Director of the National Center for 
     Research Resources shall make grants (to be referred to as 
     `innovative medical science awards') to support individual 
     clinical research projects.
       ``(2) Applications.--An application for a grant under this 
     subsection shall be submitted by an individual scientist at 
     such time as the Director requires.
       ``(3) Limitations.--The amount of a grant under this 
     subsection shall not exceed $100,000 per year per grant.
       ``(4) Authorization of appropriations.--There are 
     authorized to be appropriated to make grants under paragraph 
     (1), such sums as may be necessary for fiscal year 1997.
       ``(c) Peer Review.--The Director of NIH, in cooperation 
     with the Director of the National Center for Research 
     Resources, shall establish peer review mechanisms to evaluate 
     applications for clinical research fellowships, clinical 
     research career enhancement awards, and innovative medical 
     science award programs. Such review mechanisms shall include 
     individuals who are exceptionally qualified to appraise the 
     merits of potential clinical research trainees.''.

     SEC. 384. WAIVER OF LIMITATIONS.

       Section 481A (42 U.S.C. 287a-2) is amended--
       (1) in subsection (b)(3)(A), by striking ``9'' and 
     inserting ``12'';
       (2) in subsection (e)--
       (A) in paragraph (1)--
       (i) in subparagraph (A), by striking ``50'' and inserting 
     ``40''; and
       (ii) in subparagraph (B), by striking ``40'' and inserting 
     ``30''; and
       (B) in paragraph (4), by striking ``for applicants meeting 
     the conditions described in paragraphs (1) and (2) of 
     subsection (c)''; and
       (3) in subsection (h), by striking $150,000,000'' and all 
     that follows through ``1996'' and inserting ``such sums as 
     may be necessary for fiscal year 1997''.
                Subtitle J--National Library of Medicine

     SEC. 391. AUTHORIZATION OF APPROPRIATIONS.

       Section 468(a) (42 U.S.C. 286a-2(a)) is amended by striking 
     ``$150,000,000'' and all that follows through the period and 
     inserting ``$160,000,000 for fiscal year 1997.''.

     SEC. 392. INCREASING THE CAP ON GRANT AMOUNTS.

       Section 474(b)(2) (42 U.S.C. 286b-5(b)(2)) is amended by 
     striking ``$1,000,000'' and inserting ``$1,250,000''.
                     TITLE IV--AWARDS AND TRAINING

     SEC. 401. MEDICAL SCIENTIST TRAINING PROGRAM.

       (a) Expansion of Program.--Notwithstanding any other 
     provision of law, the Secretary of Health and Human Services, 
     acting through the Director of the National Institutes of 
     Health, shall expand the Medical Scientist Training Program 
     to include fields that will contribute to training clinical 
     investigators in the skills of performing patient-oriented 
     clinical research.
       (b) Designation of Slots.--In carrying out subsection (a), 
     the Director of the National Institutes of Health shall 
     designate a specific percentage of positions under the 
     Medical Scientist Training Program for use with respect to 
     the pursuit of a Ph.D. degree in the disciplines of 
     economics, epidemiology, public health, bioengineering, 
     biostatistics and bioethics, and other fields determined 
     appropriate by the Director.

[[Page S11768]]

     SEC. 402. RAISE IN MAXIMUM LEVEL OF LOAN REPAYMENTS.

       (a) Repayment Programs With Respect to AIDS.--Section 487A 
     (42 U.S.C. 288-1) is amended--
       (1) in subsection (a), by striking ``$20,000'' and 
     inserting ``$35,000''; and
       (2) in subsection (c), by striking ``1996'' and inserting 
     ``1997''.
       (b) Repayment Programs With Respect to Contraception and 
     Infertility.--Section 487B(a) (42 U.S.C. 288-2(a)) is amended 
     by striking ``$20,000'' and inserting ``$35,000''.
       (c) Repayment Programs With Respect to Research 
     Generally.--Section 487C(a)(1) (42 U.S.C. 288-3(a)(1)) is 
     amended by striking ``$20,000'' and inserting ``$35,000''.
       (d) Repayment Programs With Respect to Clinical Researchers 
     From Disadvantaged Backgrounds.--Section 487E(a) (42 U.S.C. 
     288-5(a)) is amended--
       (1) in paragraph (1), by striking ``$20,000'' and inserting 
     ``$35,000''; and
       (2) in paragraph (3), by striking ``338C'' and inserting 
     ``338B, 338C''.

     SEC. 403. GENERAL LOAN REPAYMENT PROGRAM.

       Part G of title IV (42 U.S.C. 288 et seq.) is amended by 
     inserting after section 487E, the following new section:

     ``SEC. 487F. GENERAL LOAN REPAYMENT PROGRAM.

       ``(a) Establishment.--
       ``(1) In general.--The Secretary, acting through the 
     Director of NIH, shall carry out a program of entering into 
     agreements with appropriately qualified health professionals 
     under which such health professionals agree to conduct 
     research with respect to the areas identified under paragraph 
     (2) in consideration of the Federal Government agreeing to 
     repay, for each year of such service, not more than $35,000 
     of the principal and interest of the educational loans of 
     such health professionals.
       ``(2) Research areas.--In carrying out the program under 
     paragraph (1), the Director of NIH shall annually identify 
     areas of research for which loan repayments made be awarded 
     under paragraph (1).
       ``(3) Term of agreement.--A loan repayment agreement under 
     paragraph (1) shall be for a minimum of two years.
       ``(b) Applicability of Certain Provisions.--With respect to 
     the National Health Service Corps Loan Repayment Program 
     established in subpart III of part D of title III, the 
     provisions of such subpart shall, except as inconsistent with 
     subsection (a) of this section, apply to the program 
     established in such subsection (a) in the same manner and to 
     the same extent as such provisions apply to the National 
     Health Service Corps Loan Repayment Program established in 
     such subpart.
       ``(c) Authorization of Appropriations.--For the purpose of 
     carrying out this section, there are authorized to be 
     appropriated such sums as may be necessary for fiscal year 
     1997.''.

     SEC. 404. CLINICAL RESEARCH ASSISTANCE.

       (a) National Research Service Awards.--Section 487(a)(1)(C) 
     (42 U.S.C. 288(a)(1)(C)) is amended--
       (1) by striking ``50 such'' and inserting ``100 such''; and
       (2) by striking ``1996'' and inserting ``1997''.
       (b) Loan Repayment Program.--Section 487E (42 U.S.C. 288-5) 
     is amended--
       (1) in the section heading, by striking ``from 
     disadvantaged backgrounds'';
       (2) in subsection (a)(1), by striking ``who are from 
     disadvantaged backgrounds'';
       (3) in subsection (b)--
       (A) by striking ``Amounts'' and inserting the following:
       ``(1) In general.--Amounts''; and
       (B) by adding at the end thereof the following new 
     paragraph:
       ``(2) Disadvantaged backgrounds set-aside.--In carrying out 
     this section, the Secretary shall ensure that not less than 
     50 percent of the amounts appropriated for a fiscal year are 
     used for contracts involving those appropriately qualified 
     health professionals who are from disadvantaged 
     backgrounds.''; and
       (4) by adding at the end thereof the following new 
     subsections:
       ``(c) Clinical Research Training Position.--A position 
     shall be considered a clinical research training position 
     under subsection (a)(1) if such position involves an 
     individual serving in a general clinical research center or 
     other organizations and institutions determined to be 
     appropriate by the Director of NIH, or a physician receiving 
     a clinical research career enhancement award or NIH 
     intramural research fellowship.
       ``(d) Authorization of Appropriations.--There are 
     authorized to be appropriated to carry out this section such 
     sums as may be necessary for each fiscal year.''.
                 TITLE V--RESEARCH WITH RESPECT TO AIDS

     SEC. 501. COMPREHENSIVE PLAN FOR EXPENDITURE OF AIDS 
                   APPROPRIATIONS.

       Section 2353(d)(1) (42 U.S.C. 300cc-40b(d)(1)) is amended 
     by striking ``through 1996'' and inserting ``through 1997''.

     SEC. 502. EMERGENCY AIDS DISCRETIONARY FUND.

       Section 2356(g)(1) (42 U.S.C. 300cc-43(g)(1)) is amended by 
     striking ``$100,000,000'' and all that follows through the 
     period and inserting ``such sums as may be necessary for 
     fiscal year 1997.''.
                      TITLE VI--GENERAL PROVISIONS
              Subtitle A--Authority of the Director of NIH

     SEC. 601. AUTHORITY OF THE DIRECTOR OF NIH.

       Section 402(b) (42 U.S.C. 282(b)) is amended--
       (1) in paragraph (11), by striking ``and'' at the end 
     thereof;
       (2) in paragraph (12), by striking the period and inserting 
     a semicolon; and
       (3) by adding after paragraph (12), the following new 
     paragraphs:
       ``(13) may conduct and support research training--
       ``(A) for which fellowship support is not provided under 
     section 487; and
       ``(B) which does not consist of residency training of 
     physicians or other health professionals; and
       ``(14) may appoint physicians, dentists, and other health 
     care professionals, subject to the provisions of title 5, 
     United States Code, relating to appointments and 
     classifications in the competitive service, and may 
     compensate such professionals subject to the provisions of 
     chapter 74 of title 38, United States Code.''.
              Subtitle B--Office of Rare Disease Research

     SEC. 611. ESTABLISHMENT OF OFFICE FOR RARE DISEASE RESEARCH.

       Part A of title IV of the Public Health Service Act (42 
     U.S.C. 281 et seq.) is amended by adding at the end thereof 
     the following new section:

     ``SEC. 404F. OFFICE FOR RARE DISEASE RESEARCH.

       ``(a) Establishment.--There is established within the 
     Office of the Director of the National Institutes of Health 
     an office to be known as the Office for Rare Disease Research 
     (in this section referred to as the `Office'). The Office 
     shall be headed by a director, who shall be appointed by the 
     Director of the National Institutes of Health.
       ``(b) Purpose.--The purpose of the Office is to promote and 
     coordinate the conduct of research on rare diseases through a 
     strategic research plan and to establish and manage a rare 
     disease research clinical database.
       ``(c) Advisory Council.--The Secretary shall establish an 
     advisory council for the purpose of providing advice to the 
     director of the Office concerning carrying out the strategic 
     research plan and other duties under this section. Section 
     222 shall apply to such council to the same extent and in the 
     same manner as such section applies to committees or councils 
     established under such section.
       ``(d) Duties.--In carrying out subsection (b), the director 
     of the Office shall--
       ``(1) develop a comprehensive plan for the conduct and 
     support of research on rare diseases;
       ``(2) coordinate and disseminate information among the 
     institutes and the public on rare diseases;
       ``(3) support research training and encourage the 
     participation of a diversity of individuals in the conduct of 
     rare disease research;
       ``(4) identify projects or research on rare diseases that 
     should be conducted or supported by the National Institutes 
     of Health;
       ``(5) develop and maintain a central database on current 
     government sponsored clinical research projects for rare 
     diseases;
       ``(6) determine the need for registries of research 
     subjects and epidemiological studies of rare disease 
     populations; and
       ``(7) prepare biennial reports on the activities carried 
     out or to be carried out by the Office and submit such 
     reports to the Secretary and the Congress.''.
                  Subtitle C--Certain Reauthorizations

     SEC. 621. NATIONAL RESEARCH SERVICE AWARDS.

       Section 487(d) (42 U.S.C. 288(d)) is amended by striking 
     ``$400,000,000'' and all that follows through the first 
     period and inserting ``such sums as may be necessary for 
     fiscal year 1997.''.

     SEC. 622. NATIONAL FOUNDATION FOR BIOMEDICAL RESEARCH.

       Section 499(m)(1) (42 U.S.C. 290b(m)(1)) is amended by 
     striking ``an aggregate'' and all that follows through the 
     period and inserting ``such sums as may be necessary for 
     fiscal year 1997.''.
                  Subtitle D--Miscellaneous Provisions

     SEC. 631. ESTABLISHMENT OF NATIONAL FUND FOR HEALTH RESEARCH.

       Part A of title IV (42 U.S.C. 281 et seq.), as amended by 
     section 611, is further amended by adding at the end thereof 
     the following new section:

     ``SEC. 404G. ESTABLISHMENT OF NATIONAL FUND FOR HEALTH 
                   RESEARCH.

       ``(a) Establishment.--There is established in the Treasury 
     of the United States a fund, to be known as the `National 
     Fund for Health Research' (hereafter in this section referred 
     to as the `Fund'), consisting of such amounts as are 
     transferred to the Fund and any interest earned on investment 
     of amounts in the Fund.
       ``(b)  Obligations From Fund.--
       ``(1) In general.--Subject to the provisions of paragraph 
     (2), with respect to the amounts made available in the Fund 
     in a fiscal year, the Secretary shall distribute all of such 
     amounts during any fiscal year to research institutes and 
     centers of the National Institutes of Health in the same 
     proportion to the total amount received under this section, 
     as the amount of annual appropriations under appropriations 
     Acts for each member institute and centers for the fiscal 
     year bears to the total amount of appropriations under 
     appropriations Acts for all research institutes and centers 
     of the National Institutes of Health for the fiscal year.
       ``(2) Trigger and release of monies.--No expenditure shall 
     be made under paragraph (1) during any fiscal year in which 
     the annual amount appropriated for the National

[[Page S11769]]

     Institutes of Health is less than the amount so appropriated 
     for the prior fiscal year.''.

     SEC. 632. DEFINITION OF CLINICAL RESEARCH.

       Part A of title IV (42 U.S.C. 281 et seq.) as amended by 
     sections 611 and 631, is further amended by adding at the end 
     thereof the following new section:

     ``SEC. 404H. DEFINITION OF CLINICAL RESEARCH.

       ``As used in this title, the term `clinical research' means 
     patient oriented clinical research conducted with human 
     subjects, or research on the causes and consequences of 
     disease in human populations, or on material of human origin 
     (such as tissue specimens and cognitive phenomena) for which 
     an investigator or colleague directly interacts with human 
     subjects in an outpatient or inpatient setting to clarify a 
     problem in human physiology, pathophysiology, or disease, 
     epidemiologic or behavioral studies, outcomes research, or 
     health services research.''.

     SEC. 633. ESTABLISHMENT OF A PEDIATRIC RESEARCH INITIATIVE.

       Part A of title IV (42 U.S.C. 281 et seq.), as amended by 
     sections 611, 631, and 632, is further amended by adding at 
     the end the following new section:

     ``SEC. 404I. PEDIATRIC RESEARCH INITIATIVE

       ``(a) Establishment.--The Secretary shall establish within 
     the Office of the Director of NIH a Pediatric Research 
     Initiative (hereafter in this section referred to as the 
     `Initiative'). The Initiative shall be headed by the Director 
     of NIH.
       ``(b) Purpose.--The purpose of the Initiative is to provide 
     funds to enable the Director of NIH to encourage--
       ``(1) increased support for pediatric biomedical research 
     within the National Institutes of Health to ensure that the 
     expanding opportunities for advancement in scientific 
     investigations and care for children are realized;
       ``(2) enhanced collaborative efforts among the Institutes 
     to support multidisciplinary research in the areas that the 
     Director deems most promising;
       ``(3) increased support for pediatric outcomes and medical 
     effectiveness research to demonstrate how to improve the 
     quality of children's health care while reducing cost;
       ``(4) the development of adequate pediatric clinical trials 
     and pediatric use information to promote the safer and more 
     effective use of prescription drugs in the pediatric 
     population; and
       ``(5) recognition of the special attention pediatric 
     research deserves.
       ``(c) Duties.--In carrying out subsection (b), the Director 
     of NIH shall--
       ``(1) consult with the Institutes and other advisors as the 
     Director determines appropriate when considering the role of 
     the Institute for Child Health and Human Development;
       ``(2) have broad discretion in the allocation of any 
     Initiative assistance among the Institutes, among types of 
     grants, and between basic and clinical research so long as 
     the--
       ``(A) assistance is directly related to the illnesses and 
     diseases of children; and
       ``(B) assistance is extramural in nature; and
       ``(3) be responsible for the oversight of any newly 
     appropriated Initiative funds and be accountable with respect 
     to such funds to Congress and to the public.
       ``(d) Authorization.--There is authorized to be 
     appropriated to carry out this section, $50,000,000 for 
     fiscal years 1997 through 1999.
       ``(e) Transfer of Funds.--The Director of NIH may transfer 
     amounts appropriated to any of the Institutes for a fiscal 
     year to the Initiative to carry out this section.''.

     SEC. 634. DIABETES RESEARCH.

       (a) Findings.--The Congress finds as follows:
       (1) Diabetes is a serious health problem in America.
       (2) More than 16,000,000 Americans suffer from diabetes.
       (3) Diabetes is the fourth leading cause of death in 
     America, taking the lives of more than 169,000 people 
     annually.
       (4) Diabetes disproportionately affects minority 
     populations, especially African-Americans, Hispanics, and 
     Native Americans.
       (5) Diabetes is the leading cause of new blindness in 
     adults over age 30.
       (6) Diabetes is the leading cause of kidney failure 
     requiring dialysis or transplantation, affecting more than 
     56,000 Americans each year.
       (7) Diabetes is the leading cause of nontraumatic 
     amputations, affecting 54,000 Americans each year.
       (8) The cost of treating diabetes and its complications are 
     staggering for our Nation.
       (9) Diabetes accounted for health expenditures of 
     $105,000,000,000 in 1992.
       (10) Diabetes accounts for over 14 percent of our Nation's 
     health care costs.
       (11) Federal funds invested in diabetes research over the 
     last two decades has led to significant advances and, 
     according to leading scientists and endocrinologists, has 
     brought the United States to the threshold of revolutionary 
     discoveries which hold the potential to dramatically reduce 
     the economic and social burden of this disease.
       (12) The National Institute of Diabetes and Digestive and 
     Kidney Diseases supports, in addition to many other areas of 
     research, genetic research, islet cell transplantation 
     research, and prevention and treatment clinical trials 
     focusing on diabetes. Other research institutes within the 
     National Institutes of Health conduct diabetes-related 
     research focusing on its numerous complications, such as 
     heart disease, eye and kidney problems, amputations, and 
     diabetic neuropathy.
       (b) Increased Funding Regarding Diabetes.--With respect to 
     the conduct and support of diabetes-related research by the 
     National Institutes of Health, there are authorized to be 
     appropriated for such purpose--
       (1) for each of the fiscal years 1997 through 1999, an 
     amount equal to the amount appropriated for such purpose for 
     fiscal year 1996; and
       (2) for the 3-fiscal year period beginning with fiscal year 
     1997, an additional amount equal to 25 percent of the amount 
     appropriated for such purpose for fiscal year 1996.

     SEC. 635. PARKINSON'S RESEARCH.

       Part B of title IV (42 U.S.C. 284 et seq.), as amended by 
     sections 204, 382 and 383, is further amended by adding at 
     the end the following section:


                         ``parkinson's disease

       ``Sec. 409E. (a) In General.--The Director of NIH shall 
     establish a program for the conduct and support of research 
     and training with respect to Parkinson's disease.
       ``(b) Inter-institute Coordination.--
       ``(1) In general.--The Director of NIH shall provide for 
     the coordination of the program established under subsection 
     (a) among all of the national research institutes conducting 
     Parkinson's research.
       ``(2) Conference.--Coordination under paragraph (1) shall 
     include the convening of a research planning conference not 
     less frequently than once every 2 years. Each such conference 
     shall prepare and submit to the Committee on Appropriations 
     and the Committee on Labor and Human Resources of the Senate 
     and the Committee on Appropriations and the Committee on 
     Commerce of the House of Representatives a report concerning 
     the conference.
       ``(c) Morris K. Udall Research Centers.--
       ``(1) In general.--The Director of NIH shall award Core 
     Center Grants to encourage the development of innovative 
     multidisciplinary research and provide training concerning 
     Parkinson's. The Director shall award not more than 10 Core 
     Center Grants and designate each center funded under such 
     grants as a Morris K. Udall Center for Research on 
     Parkinson's Disease.
       ``(2) Requirements.--
       ``(A) In general.--With respect to Parkinson's, each center 
     assisted under this subsection shall--
       ``(i) use the facilities of a single institution or a 
     consortium of cooperating institutions, and meet such 
     qualifications as may be prescribed by the Director of the 
     NIH; and
       ``(ii) conduct basic and clinical research.
       ``(B) Discretionary requirements.--With respect to 
     Parkinson's, each center assisted under this subsection may--
       ``(i) conduct training programs for scientists and health 
     professionals;
       ``(ii) conduct programs to provide information and 
     continuing education to health professionals;
       ``(iii) conduct programs for the dissemination of 
     information to the public;
       ``(iv) separately or in collaboration with other centers, 
     establish a nationwide data system derived from patient 
     populations with Parkinson's, and where possible, comparing 
     relevant data involving general populations;
       ``(v) separately or in collaboration with other centers, 
     establish a Parkinson's Disease Information Clearinghouse to 
     facilitate and enhance knowledge and understanding of 
     Parkinson's disease; and
       ``(vi) separately or in collaboration with other centers, 
     establish a national education program that fosters a 
     national focus on Parkinson's and the care of those with 
     Parkinson's.
       ``(3) Stipends regarding training programs.--A center may 
     use funds provided under paragraph (1) to provide stipends 
     for scientists and health professionals enrolled in training 
     programs under paragraph (2)(B).
       ``(4) Duration of support.--Support of a center under this 
     subsection may be for a period not exceeding five years. Such 
     period may be extended by the Director of NIH for one or more 
     additional periods of not more than five years if the 
     operations of such center have been reviewed by an 
     appropriate technical and scientific peer review group 
     established by the Director and if such group has recommended 
     to the Director that such period should be extended.
       ``(d) Morris K. Udall Awards for Innovation in Parkinson's 
     Disease Research.--The Director of NIH shall establish a 
     grant program to support innovative proposals leading to 
     significant breakthroughs in Parkinson's research. Grants 
     under this subsection shall be available to support 
     outstanding neuroscientists and clinicians who bring 
     innovative ideas to bear on the understanding of the 
     pathogenesis, diagnosis and treatment of Parkinson's disease.
       ``(e) Authorization of Appropriations.--For the purpose of 
     carrying out this section, there are authorized to be 
     appropriated $80,000,000 for fiscal year 1997.''.

     SEC. 636. PAIN RESEARCH CONSORTIUM.

       (a) Short Title.--This section may be cited as the ``Pain 
     Research Consortium Act of 1996''.
       (b) Operation.--Part E of title IV (42 U.S.C. 287 et seq.) 
     is amended by adding at the end thereof the following new 
     subpart:

[[Page S11770]]

                 ``Subpart 5--Pain Research Consortium

     ``SEC. 485E. ESTABLISHMENT AND PURPOSE OF THE CONSORTIUM.

       ``(a) Establishment.--The Director of NIH shall, subject to 
     the availability of appropriations, and acting in cooperation 
     with appropriate Institutes and with leading experts in pain 
     research and treatment, establish within the National 
     Institutes of Health, a Pain Research Consortium (hereafter 
     referred to in this subpart as the `Consortium').
       ``(b) Purpose.--It is the purpose of the Pain Research 
     Consortium to--
       ``(1) provide a structure for coordinating pain research 
     activities;
       ``(2) facilitate communications among Federal and State 
     governmental agencies and private sector organization 
     (including extramural grantees) concerned with pain;
       ``(3) share information concerning research and related 
     activities being conducted in the area of pain;
       ``(4) encourage the recruitment and retention of 
     individuals desiring to conduct pain research;
       ``(5) develop collaborative pain research efforts;
       ``(6) avoid unnecessary duplication of pain research 
     efforts; and
       ``(7) achieve a more efficient use of Federal and private 
     sector research funds.
       ``(c) Composition.--The Consortium shall be composed of 
     representatives of--
       ``(1) the National Institute of Neurological Disorders and 
     Stroke;
       ``(2) the National Institute of Drug Abuse;
       ``(3) the National Institute of General Medical Sciences;
       ``(4) the National Institute of Dental Research;
       ``(5) the National Health, Lung, and Blood Institute;
       ``(6) the National Cancer Institute;
       ``(7) the National Institute of Mental Health;
       ``(8) the National Institute of Nursing Research;
       ``(9) the National Center for Research Resources;
       ``(10) the National Institute of Child Health and Human 
     Development;
       ``(11) the National Institute of Arthritis and 
     Musculoskeletal and Skin Diseases;
       ``(12) the National Institute on Aging;
       ``(13) pain management practitioners, which may include 
     physicians, psychologists, physical medicine and 
     rehabilitation service representatives (including physical 
     therapists and occupational therapists), nurses, dentists, 
     and chiropractors; and
       ``(14) patient advocacy groups.
       ``(d) Activities.--The Consortium shall coordinate and 
     support research, training, health information dissemination 
     and related activities with respect to--
       ``(1) acute pain;
       ``(2) cancer and HIV-related pain;
       ``(3) back pain, headache pain, and facial pain; and
       ``(4) other painful conditions.
       ``(e) Authorization of Appropriations.--There is authorized 
     to be appropriated to carry out this section, $5,000,000 for 
     fiscal year 1997.''.
             Subtitle E--Repeals and Conforming Amendments

     SEC. 641. REPEALS AND CONFORMING AMENDMENTS.

       (a) Renaming of Division of Research Resources.--Section 
     403(5) (42 U.S.C. 283(5)) is amended by striking ``Division 
     of Research Resources'' and inserting ``National Center for 
     Research Resources''.
       (b) Renaming of National Center for Nursing Research.--
       (1) Section 403(5) (42 U.S.C. 283(5)) is amended by 
     striking ``National Center for Nursing Research'' and 
     inserting ``National Institute of Nursing Research''.
       (2) Section 408(a)(2) (42 U.S.C. 284c(a)(2)) is amended by 
     striking ``National Center for Nursing Research'' and 
     inserting ``National Institute of Nursing Research''.
       (c) Renaming of Chief Medical Director for Veterans 
     Affairs.--
       (1) Section 406 (42 U.S.C. 284a) is amended--
       (A) in subsection (b)(2)(A), by striking ``Chief Medical 
     Director of the Department of Veterans Affairs or the Chief 
     Dental Director of the Department of Veterans Affairs'' and 
     inserting ``Under Secretary for Health of the Department of 
     Veterans Affairs''; and
       (B) in subsection (h)(2)(A)(v) by striking ``Chief Medical 
     Director of the Department of Veterans Affairs,'' and 
     inserting ``Under Secretary for Health of the Department of 
     Veterans Affairs''.
       (2) Section 424(c)(3)(B)(x) (42 U.S.C. 285b-7(c)(3)(B)(x)) 
     is amended by striking ``Chief Medical Director of the 
     Veterans' Administration'' and inserting ``Under Secretary 
     for Health of the Department of Veterans Affairs''.
       (3) Section 429(b) (42 U.S.C. 285c-3(b)) is amended by 
     striking ``Chief Medical Director of the Veterans' 
     Administration'' and inserting ``Under Secretary for Health 
     of the Department of Veterans Affairs''.
       (4) Section 430(b)(2)(A)(i) (42 U.S.C. 285c-4(b)(2)(A)(i)) 
     is amended by striking ``Chief Medical Director of the 
     Department of Veterans Affairs'' and inserting ``Under 
     Secretary for Health of the Department of Veterans Affairs''.
       (5) Section 439(b) (42 U.S.C. 285d-4(b)) is amended by 
     striking ``Chief Medical Director of the Department of 
     Veterans Affairs'' and inserting ``Under Secretary for Health 
     of the Department of Veterans Affairs''.
       (6) Section 452(f)(3)(B)(xi) (42 U.S.C. 285g-
     4(f)(3)(B)(xi)) is amended by striking ``Chief Medical 
     Director of the Department of Veterans Affairs'' and 
     inserting ``Under Secretary for Health of the Department of 
     Veterans Affairs''.
       (7) Section 466(a)(1)(B) (42 U.S.C. 286a(a)(1)(B)) is 
     amended by striking ``Chief Medical Director of the 
     Department of Veterans Affairs'' and inserting ``Under 
     Secretary for Health of the Department of Veterans Affairs''.
       (8) Section 480(b)(2)(A) (42 U.S.C. 287a(b)(2)(A)) is 
     amended by striking ``Chief Medical Director of the 
     Department of Veterans Affairs'' and inserting ``Under 
     Secretary for Health of the Department of Veterans Affairs''.
       (b) Advisory Councils.--Section 406(h) (42 U.S.C. 284a(h)) 
     is amended--
       (1) by striking paragraph (1); and
       (2) in paragraph (2)--
       (A) by striking ``(2)(A) The'' and inserting ``(1) The'';
       (B) by redesignating subparagraph (B) as paragraph (2); and
       (C) by redesignating clauses (i) through (vi) of paragraph 
     (1) (as so redesignated) as subparagraphs (A) through (F), 
     respectively.
       (c) Diabetes and Digestive and Kidney Disorders Advisory 
     Boards.--Section 430 (42 U.S.C. 285c-4) is repealed.
       (d) National Arthritis and Musculoskeletal and Skin 
     Diseases Advisory Board.--Section 442 (42 U.S.C. 285d-7) is 
     repealed.
       (e) Research Centers Regarding Chronic Fatigue Syndrome.--
     Subpart 6 of part C of title IV (42 U.S.C. 285f et seq.) is 
     amended by redesignating the second section 447 (42 U.S.C. 
     285f-1) as section 447A.
       (f) National Institute on Deafness Advisory Board.--Section 
     464D (42 U.S.C. 285m-4) is repealed.
       (g) Biomedical and Behavioral Research Personnel Study.--
     Section 489 (42 U.S.C. 288b) is amended--
       (1) by striking subsection (b); and
       (2) by redesignating subsection (c) as subsection (b).
       (h) National Commission on Alcoholism and Other Alcohol-
     Related Problems.--Section 18 of the Comprehensive Alcohol 
     Abuse and Alcoholism Prevention, Treatment, and 
     Rehabilitation Act Amendments of 1979 (42 U.S.C. 4541 note) 
     is repealed.
       (i) Advisory Council on Hazardous Substances Research and 
     Training.--Section 311(a) of the Comprehensive Environmental 
     Response, Compensation and Liability Act of 1980 (42 U.S.C. 
     9660(a)) is amended--
       (1) by striking paragraph (5); and
       (2) in the last sentence of paragraph (6), by striking 
     ``the relevant Federal agencies referred to in subparagraph 
     (A) of paragraph (5)'' and inserting ``relevant Federal 
     agencies''.

  The PRESIDING OFFICER. The Senator from Oklahoma, the acting leader.

                          ____________________